Nick Pizzie insider trades
Open-market stock purchases and sales by Nick Pizzie, Chief Financial Officer at Axsome Therapeutics, Inc, from SEC Form 4 filings since May 16, 2018.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +203%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $7.9M |
| Jun 9, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Apr 21, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
| Jan 22, 2026 | AXSM Axsome Therapeutics, Inc | Sold | $2.3M |
| Jan 22, 2026 | AXSM Axsome Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- AXSM Axsome Therapeutics, Inc: 11 buys, 4 sales, last Jun 9, 2026